G
Gabriel Rubio
Researcher at Complutense University of Madrid
Publications - 227
Citations - 5224
Gabriel Rubio is an academic researcher from Complutense University of Madrid. The author has contributed to research in topics: Alcohol dependence & Alcohol use disorder. The author has an hindex of 36, co-authored 216 publications receiving 4578 citations. Previous affiliations of Gabriel Rubio include University of Barcelona & Mental Health Services.
Papers
More filters
Journal ArticleDOI
A bibliometric study of scientific research conducted on second-generation antipsychotic drugs in Singapore
Francisco López-Muñoz,Kang Sim,Winston W. Shen,Lorena Huelves,Raquel Moreno,Juan D. Molina,Gabriel Rubio,Concha Noriega,Miguel A. Pérez-Nieto,Cecilio Alamo +9 more
TL;DR: In this paper, a bibliometric study was carried out to ascertain the volume and impact of scientific literature published on second-generation antipsychotic drugs (SGAs) in Singapore from 1997 to 2011.
Journal ArticleDOI
DSM-5 en pacientes que solicitan el primer tratamiento del trastorno por uso de alcohol. Diferencias de sexo en el estudio multicéntrico CohRTA
Arantza Sanvisens,Paola Zuluaga,Gabriel Rubio,Antoni Short,Antoni Gual,Francisco Javier Álvarez,Marta Torrens,Fernando Rodríguez de Fonseca,Roberto Muga Bustamante,Estudio CohRTA Estudio CohRTA +9 more
TL;DR: Analyzing sex differences in the DSM-5 criteria among patients admitted to their first treatment of alcohol use disorder (AUD) found social impairment and risky alcohol use are significantly more frequent in men.
Journal ArticleDOI
P3 Component as a Potential Endophenotype for Control Inhibition in Offspring of Alcoholics.
Isabel Domínguez-Centeno,Rosa Jurado-Barba,Ana Sion,Andrés Martínez-Maldonado,Gabriela Castillo-Parra,Francisco López-Muñoz,Francisco López-Muñoz,Gabriel Rubio,Isabel Martínez-Gras +8 more
TL;DR: The absence of differences between the P3 Go and No-Go observed in the OA group can be interpreted as a possible alteration related with inhibition, in a way that they may need to recruit similar resources for inhibitory and classificational processes for both conditions.
Journal ArticleDOI
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases.
Nuria García-Marchena,Rosa Maza-Quiroga,Antonia Serrano,Vicente Barrios,Nerea Requena-Ocaña,Juan Suárez,Julie A. Chowen,Jesús Argente,Gabriel Rubio,Marta Torrens,Meritxell López-Gallardo,Eva M. Marco,Estela Castilla-Ortega,Luis J. Santín,Fernando Rodríguez de Fonseca,Francisco Javier Pavón,Francisco Javier Pavón,Pedro Araos +17 more
TL;DR: Alcohol use disorder is associated with alterations of plasma cytokines, being interleukin 6 and interLEukin 17A potential biomarkers of the presence of comorbidities of digestive organs, according to the clinical relevance of alcohol-induced inflammatory processes.
Journal ArticleDOI
Oxcarbacepina para la prevención de patología epiléptica en la desintoxicación alcohólica
TL;DR: La OXC puede ser una alternativa util a la BZD y otros tratamientos farmacologicos para the prevencion of complicaciones en el trat amiento de desintoxicacion, en especial por the ausencia of capacidad adictiva y por poseer un mejor perfil of seguridad que los anticonvulsionantes clasicos.